{"disease":{"id":"acute-hiv-infection","name":"acute hiv infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01434706","title":"Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":22607,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT05728996","title":"Netherlands Cohort Study on Acute HIV Infection","phase":"","overall_status":"RECRUITING","enrollment_count":183,"lead_sponsor_name":"Prof. Jan Prins","has_results":false},{"nct_id":"NCT05719441","title":"A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06484335","title":"RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","has_results":false},{"nct_id":"NCT03711253","title":"Empiric Treatment for Acute HIV in the ED","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02170246","title":"Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT03579381","title":"Specimen Repository for HIV Immunopathogenesis","phase":"","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"AIDS Healthcare Foundation","has_results":false},{"nct_id":"NCT04083170","title":"Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}